For two years, “60 Minutes” followed a clinical trial at Duke University that uses a re-engineered polio virus to attack glioblastoma. The early tests have been so successful that the Food and Drug Administration fast tracked the treatment while it’s still being evaluated for final approval.
Watch the “60 Minutes” episode “Breakthrough Status” featuring Duke Neurosurgery’s Annick Desjardins, MD; Henry Friedman, MD; Matthias Gromeier, MD; and Darell Bigner, MD, PhD.